Loading...
Loading...
Browse all stories on DeepNewz
VisitWhat will be identified as the primary reason for DTaP vaccination rate decline by 2025?
Vaccine hesitancy • 25%
Waning vaccine protection • 25%
Lack of access to healthcare • 25%
Other • 25%
CDC and major health studies and reports
U.S. Whooping Cough Cases Surge to Over 32,000, a 6-Fold Increase, Amid Vaccine Hesitancy
Dec 24, 2024, 11:00 AM
The United States is experiencing the highest number of whooping cough cases in a decade, with over 32,000 cases recorded this year. This represents a six-fold increase compared to the same period last year, when 5,100 cases were reported. The surge in cases is attributed to several factors, including a decline in vaccination rates, waning vaccine protection, and improved testing capabilities. Infants are particularly vulnerable, with the disease posing a high risk of infection and severe complications. Experts have noted an increase in vaccine hesitancy, leading to more unvaccinated children contracting whooping cough. The Centers for Disease Control and Prevention (CDC) recommends vaccinations starting at 2 months of age, with booster shots administered throughout childhood and into adulthood. Despite high vaccination rates overall, there has been a noticeable decline in recent years, with the percentage of children receiving the required doses of the DTaP vaccine dropping from 94% to around 92.5% for those born between 2020 and 2021. The Tdap vaccine is recommended for preteens and adults.
View original story
Safety concerns • 25%
Effectiveness doubts • 25%
Natural immunity preference • 25%
Other reasons • 25%
Prevention of hospitalization • 25%
Employer or insurance requirements • 25%
Public health campaigns • 25%
Other • 25%
Increased availability • 25%
Government incentives • 25%
Public health campaigns • 25%
Other • 25%
Economic impact concerns • 25%
Political ideology • 25%
Public health strategy shift • 25%
Other reasons • 25%
Convenience • 25%
Cost • 25%
Fear of needles • 25%
Effectiveness • 25%
Increase in support • 25%
Decrease in support • 25%
No change • 25%
Mixed opinions • 25%
Safety concerns • 25%
Political pressure • 25%
Lack of demand • 25%
Other reasons • 25%
Increased awareness and screening • 25%
Environmental factors • 25%
Genetic factors • 25%
Other • 25%
Increased support for vaccinations • 25%
Decreased support for vaccinations • 25%
No significant change • 25%
Increased demand for alternative vaccines • 25%
Waning vaccine immunity • 25%
Pathogen evolution • 25%
Decreased vaccine coverage • 25%
Other • 25%
Adults (20+ years) • 25%
Infants (0-1 year) • 25%
Children (2-12 years) • 25%
Teenagers (13-19 years) • 25%